Coya Therapeutics, Inc.

NASDAQ:COYA

Biotechnology

Healthcare
$2.98 -3.18%

-$0.16 today

Market cap
$69.90M
Beta
0.62
P/E (TTM)
-3.9
EPS (TTM)
-$1.26
52W Low $3.71High $7.75

Volume 0.07M

Average 0.16M

Income Statement

Follow revenue through to earnings.

Revenue

$7.95M

FY 2025 · Annual

+123.6% YoY

Operating Income

-$20.27M

FY 2025 · Annual

Net Income

-$21.23M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue006M3.55M7.95M
Cost of Revenue04.41M5.5M11.87M27.36K
Gross Profit0(4.41M)500.68K(8.31M)7.92M
Gross Margin——8.3%-233.9%99.7%
Research & Development2.54M4.94M6.04M11.89M16.73M
Selling, General & Admin2.31M4.85M7.83M8.89M11.45M
Operating Expenses4.87M5.4M8.4M8.94M28.18M
Depreciation & Amortization16.13K27.36K27.36K27.36K27.36K
EBITDA(4.88M)(9.26M)(7.33M)(17.2M)(21.2M)
EBITDA Margin——-122.2%-483.9%-266.8%
Operating Income(4.87M)(9.81M)(7.9M)(17.25M)(20.27M)
Operating Margin——-131.7%-485.4%-255.0%
Interest Income00000
Interest Expense00000
Other Income / Expenses(21.48K)(2.43M)639.37K1.65M(957.4K)
Income Before Tax(4.89M)(12.24M)(7.26M)(15.6M)(21.22M)
Pre-Tax Margin——-121.0%-439.0%-267.1%
Income Tax Expense00723.85K(720.29K)3.09K
Net Income(4.89M)(12.24M)(7.99M)(14.88M)(21.23M)
Net Margin——-133.1%-418.7%-267.1%
EPS (Basic)(0.74)(1.23)(0.79)(0.98)(1.27)
EPS (Diluted)(0.74)(1.23)(0.79)(0.98)(1.27)
Weighted Avg Shares6.6M9.95M10.16M15.24M16.73M
Weighted Avg Shares (Diluted)6.6M9.95M10.16M15.24M16.73M

COYA Earnings Waterfall · TTM

NASDAQ:COYA · Revenue to Net Income

Key Ratios

EPS$-1.15
Gross Margin98.6%
Net Margin-1699.6%
P/E Ratio-5.4
P/S Ratio225.4

Analysis

$7.9M of revenue converted into -$21.1M of net income for the selected period. Gross margin is 98.6% and net margin is -1699.6%, showing how much revenue survives after costs and taxes. EPS is $-1.15, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportOct 14, 2026
8-KCurrent reportOct 5, 2026
8-KCurrent reportSep 15, 2026

How much revenue does COYA generate?

Coya Therapeutics, Inc. (COYA) reported $7.95M of revenue in fiscal 2025.

Is COYA profitable?

Coya Therapeutics, Inc. (COYA) reported -$21.23M of net income, with a net margin of -267.1%.